Business Wire

Zespri Achieves a First for Fresh Produce with EU-Approved Health Claim for Green Kiwifruit

Share

Green kiwifruit has become the first fresh fruit ever to receive an authorised health claim from the European Commission, marking a breakthrough for kiwifruit marketer Zespri and the wider fresh produce industry.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250820737646/en/

Zespri Kiwifruit

The European Commission has officially approved the health claim that "consumption of green kiwifruit contributes to normal bowel function by increasing stool frequency" – based on a daily intake of two fresh green kiwifruit (Actinidia deliciosa var. Hayward) providing a minimum of 200g of flesh.

This authorisation is among only three health claims approved by the European Commission in the last five years, following a rigorous evaluation process in which only less than 1 out of 8 claims submitted receive approval.

Zespri CEO Jason Te Brake says, “This milestone is not only a first for Zespri but for the entire fresh produce industry. The EU Commission’s recognition of green kiwifruit’s role in digestive health reflects one of the ways we are helping people thrive through the goodness of kiwifruit. The approval not only validates Zespri’s health and innovation programme, it also delivers tangible value to the industry and reflects the hard work of our green growers to produce nutritious, great-tasting kiwifruit.”

Zespri fully funded the application process and majority of the key research submitted in the scientific substantiation, committing over 15 years to documenting the benefits of green kiwifruit. The approval follows the submission of a comprehensive scientific dossier in 2018 which included 18 human intervention studies, six of which ultimately were considered as a strong basis for proving the effect of green kiwifruit on intestinal function. The European Food Safety Authority (EFSA) delivered a positive scientific opinion in 2021, which has now culminated in the Commission's formal authorisation.

This landmark achievement demonstrates the critical value of investing in health and nutrition science -both to build trust in the fresh category and to unlock further growth and demand for green kiwifruit. In 2024/25, Zespri supplied a total of 220.9 million trays (ZespriTM Green, ZespriTM RubyRedTM and ZespriTM SunGoldTM Kiwifruit) to more than 50 markets.

Zespri Green kiwifruit is packed with essential nutrients including fiber, the beneficial effects on digestive health of which are well-documented in scientific research. The European Commission has now recognized the benefits of green kiwifruit for promoting good bowel habits, confirming the added value of this delicious fruit that many consumers already experience through daily consumption.

As European consumers become increasingly proactive about their health and seek naturally nutritious foods with proven benefits, Zespri’s leadership sets a blueprint for fresh produce that science-led innovation delivers real value for consumers and the industry.

With this new authorisation, Zespri will begin integrating the health claim into its European communications, reaffirming its commitment to helping consumers make informed choices about their health.

IMAGERY

Imagery of Zespri Green Kiwifuit can be found in the following link

https://www.dropbox.com/scl/fo/jz98ececpohek5z28ok1f/AA6R9cZkQFu7oOvnqUL4ENI?rlkey=sz18pcfmh57kg0su9va3s5mie&st=sxttuz20&dl=0

LINKS

Official Journal of the European Union: https://eurlex.europa.eu/eli/reg_impl/2025/1560/oj

EFSA health claims page: https://www.efsa.europa.eu/en/topics/topic/health-claims

ABOUT ZESPRI

Zespri is 100 percent owned by current and former kiwifruit growers and has a global team of 900+ based in Mount Maunganui and throughout Asia, Europe and the Americas. Our purpose is to help people, communities and the environment thrive through the goodness of kiwifruit, and we work with 2,800 growers in New Zealand and 1,500 growers offshore to provide consumers with fresh, healthy and great-tasting Zespri Green, Zespri RubyRed and SunGold Kiwifruit. In 2024/25, we supplied 220.9 million trays (more than 795,000 tonnes) of kiwifruit to consumers in more than 50 markets, and recorded global operating revenue of NZ$5.14 billion. Zespri is committed to sustainability, with areas of improvement identified right through the supply chain including our pledge that by 2025 we will use 100 percent reusable, recyclable or compostable packaging, do more to help the environment, and work with our partners to be carbon positive by 2035.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250820737646/en/

Contacts

MEDIA CONTACT
Maria Bengtsson
Maria@united-partners.com
+34 711 016 382

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

European Commission Approves Tablet Formulation of BeOne Medicines’ BRUKINSA ® for All Approved Indications21.8.2025 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Commission has approved a new film-coated tablet formulation of BRUKINSA® (zanubrutinib) for all approved indications. "Developed to meet the real-world needs of patients, the new BRUKINSA tablet formulation aims to simplify treatment, reduce pill burden, and enhance ease of administration, reflecting our continuous focus on patient-centered innovation,” said Giancarlo Benelli, Senior Vice President and Head of Europe, BeOne. “With more than 200,000 patients treated globally and the broadest label of any BTK inhibitor in Europe, BRUKINSA's differentiated clinical profile continues to make an impact for people facing certain B-cell cancers." The recommended dose of BRUKINSA continues to be 320 mg daily. The BRUKINSA tablets are 160 mg each, allowing patients to halve their daily pill intake from four pills to two. Additionally, they are smaller than the capsules and

DSR Bank Development Group Welcomes Søren Elbech and Matthew Westerman to Its Board21.8.2025 12:18:00 EEST | Press release

The Defence, Security and Resilience Bank (DSRB) Development Group today announced the appointment of Søren Elbech and Matthew Westerman to its Board, strengthening the institution’s financial and capital markets leadership as it advances toward formal establishment. Søren Elbech brings unique multilateral banking expertise to the DSRB Board. Since September 2023, Elbech serves as Chief Risk Officer of Inter-American Development Bank. Prior, Elbech was Managing Director, Global Head of Supranational Institutions at JPMorgan and, in 2019, co-developed what since evolved into DSRB. Moreover, as the first Treasurer of the Asian Infrastructure Investment Bank (AIIB), in 2016-19 he was responsible for building its treasury function from the ground up and achieving AAA credit ratings from all leading rating agencies. Elbech’s experience in establishing the financial architecture of a new multilateral bank is shared by only a handful of individuals globally, making his contribution to the DSR

L&T Technology Services Launches PLxAI, Proprietary GenAI Framework to Accelerate Product Development21.8.2025 11:30:00 EEST | Press release

L&T Technology Services (BSE: 540115, NSE: LTTS), announced the launch of PLxAI, the Company’s proprietary GenAI-based framework to accelerate the Product Development Life Cycle for its global clients across Mobility, Sustainability, and Tech. Developed by vastly experienced PDLC SMEs, the framework uses a combination of Generative AI & Conventional AI to provide a one-stop shop to develop scalable and reusable solutions across all PDLC stages, ranging from concept design to aftermarket services support. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250820777125/en/ By accelerating the rate of innovation and optimizing costs across product development, PLxAI is poised to redefine how businesses approach product development. It incorporates advanced features like capturing and leveraging existing knowledge, including organizational and tribal knowledge, to deliver context-aware insights that enhance and optimize product engi

NIPPON KINZOKU: New Launch of “STA Finish” Stainless Steel for High-Precision Etching as an “Eco-Product”21.8.2025 04:01:00 EEST | Press release

NIPPON KINZOKU CO., LTD. (Headquarters: Minato-ku, Tokyo) is pleased to announce the launch of its fourth environmentally-friendly “Eco-Product” series, STA (Special Tension Annealing) finish stainless steel, which eliminates warping and refines crystal grain size for high-definition etching. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250820626946/en/ Conventional TA (Tension Annealing) finish has been highly evaluated as a stainless spring material with excellent flatness, low residual stress, and dimensional stability after processing. STA finish, which is a further evolution of this finish, minimizes residual stress and is optimized for etching processing. In the etching process, particularly in the half-etching process, spring material warping has been an issue. STA finish greatly reduces this warping, dramatically improving dimensional stability. Furthermore, in response to demand for smoother etched surfaces, we ha

Game Developers Can Now Unlock Full LTV and ROAS Visibility With Xsolla Web Shop’s New Mobile S2S Integration Powered by Adjust20.8.2025 18:16:00 EEST | Press release

Xsolla, a global commerce company helping developers launch, grow, and monetize their games, announces a new mobile-focused Server-to-Server (S2S) integration with Adjust, the global leader in mobile measurement and analytics. This strategic partnership empowers mobile game developers with precise, cross-platform performance tracking by bridging the gap between mobile marketing efforts and purchases made through the Xsolla Web Shop. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250820752076/en/ (Graphic: Xsolla) As more developers turn to Web Shops to drive direct-to-consumer monetization beyond traditional app stores, measuring the full value of those off-platform transactions becomes a critical challenge. Developers can now gain a complete picture of their campaign performance with Xsolla’s new S2S integration with Adjust, enabling accurate attribution of Web Shop purchases as in-app events. This seamless connection provi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye